SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending due to significant retail and institutional interest surrounding positive data from their prostate cancer therapy and the upcoming BLA filing. Investors are closely monitoring the company's progress on clinical milestones and manufacturing scale-up, while actively debating the potential for long-term institutional accumulation and future buyout opportunities.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is trending as investors weigh the significance of the fund's private market holdings against recent volatility and the looming expiration of share lockup periods. Community discourse remains deeply divided between long-term bulls highlighting exposure to high-profile AI and space startups and skeptical bears pointing to a significant disconnect between current market pricing and the fund's reported net asset value.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit Inc. is trending as investors rally around the company's confirmed inclusion in the S&P 500, a milestone that has triggered heavy after-hours volume and sparked intense debate regarding potential index-fund demand versus typical inclusion fades. The community is actively weighing the stock's future, with many highlighting strong revenue growth and data monetization as key long-term catalysts, while skeptics focus on bot prevalence and the optics of executive share sales.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is experiencing significant volatility as investors weigh strong backlog growth and revenue expectations against concerns over cash burn and potential dilution. The community is sharply divided, with bulls pointing to the company's long-term contract pipeline and sector-wide growth, while bears remain focused on high operating expenses and the timing of project executions.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is facing significant downward pressure following an analyst downgrade and uncertainty surrounding a CFO leadership transition, despite the company's robust customer growth and recent regulatory wins. Investors are actively debating whether this pullback represents an attractive long-term entry point for a dominant fintech or if broader macroeconomic headwinds and credit concerns will continue to weigh on the stock.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is facing increased volatility as investors weigh the company's strong record earnings and positive forward-looking guidance against a broader market sell-off in semiconductor stocks. While many in the community remain bullish on the long-term AI infrastructure thesis, others are actively discussing concerns about elevated valuations and the cyclical nature of the equipment sector.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently trending as investors debate whether the recent significant pullback represents a deep-value buying opportunity or a signal of fundamental weakness. The community is focused on recent insider purchasing by executives, alongside intense after-hours price activity that has sparked speculation regarding potential corporate news or institutional accumulation.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as institutional ownership and call option volume surge ahead of the long-awaited 80th event trigger for the Phase 3 REGAL trial. The community remains intensely focused on interpreting the prolonged timeline as a potential sign of drug efficacy, while active debates continue regarding a possible buyout and the future commercial potential of the SLS009 pipeline.

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Domestic Operations and International Operations segments. The company was founded on November 13, 2014 and is headquartered in Stamford, CT.

Curaleaf Holdings Inc

Curaleaf is in the spotlight as investors track its expansion strategies and M&A activities, including a high-profile takeover proposal for Aurora Cannabis. Community discussions are heavily centered on the company's international footprint and the broader sector shift toward consolidation as operators seek growth amidst regulatory challenges.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management systems, as well as other tools, integrations, and native payment solutions. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HubSpot Inc

HubSpot is under significant pressure following a report that missed growth expectations and raised concerns about the company's ability to navigate the transition to agentic AI platforms. The community remains deeply divided, with some investors viewing the steep sell-off as a valuation reset and a potential long-term buying opportunity, while others worry that AI could permanently erode the company's core software business model.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

New Strong Buy Stocks for April 10th

ESCA, GRDN, TPST, ASTE and ECG have been added to the Zacks Rank #1 (Strong Buy) List on April 10th, 2026. 

Tempest Therapeutics (NASDAQ:TPST) CEO Matthew Angel Acquires 231,482 Shares

Tempest Therapeutics, Inc. (NASDAQ:TPST - Get Free Report) CEO Matthew Angel acquired 231,482 shares of the business's stock in a transaction on Tuesday, March 24th. The shares were purchased at an average cost of $2.16 per share, for a total transaction of $500,001.12. Following the completion of...

TPST Stock Plummets After Inking Deal To Acquire CAR-T Programs From Privately-Held Firm In All-Stock Transaction

Equity

The transaction is expected to close in early 2026, provided it receives all required approvals. 


Why Tempest Therapeutics (TPST) Stock Is Down 45% Today

Tempest Therapeutics shares fell Wednesday after the announcement of an all-stock acquisition of dual-CAR T programs from Factor Bioscience.read more...

TPST Stock Up on EMA's Orphan Drug Tag for Liver Cancer Therapy

Tempest Therapeutics Retail Chatter Explodes As Cancer Drug Developer Mulls Possible Merger

CEO Stephen Brady emphasized the company's strong data and regulatory momentum, pointing to Phase 2 results for amezalpat in advanced liver cancer and FDA clearance for a pivotal Phase 3 study. 

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.

Tempest Therapeutics Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.17
Prev Close	$1.21
Open	$1.20
Dividend Yield	0.00%
50-Day Moving Average	$1.07
Beta	1.99
Avg. Volume	176,928.37
PE Ratio	-0.19

52-Week High	$12.23
52-Week Low	$0.8401
Market Capitalization	$19.34M
EPS (Annual)	-$6.33
Price to Book	20.42
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info